CONNECTA Therapeutics closes €3.1 million financing led by Clave Capital to advance clinical development of CTH120 for Fragile X syndrome.
Amount Raised
€3.1 Million
Round Type
Seed
BarcelonaBiotechnologyHealth CareTherapeuticsInvestors
Description
CONNECTA Therapeutics has closed a €3.1 million financing led by new investor Clave Capital and supported by existing investors. The funds will accelerate the Phase IIa clinical trial of CTH120 in adult males with Fragile X syndrome. This funding marks a significant milestone for the company as it aims to improve outcomes for patients. The trial is expected to provide important data in mid-2027.
Quick answer
CONNECTA Therapeutics raised €3.1 Million in a Seed round, dated September 10, 2026. Investors: Prous Institute For Biomedical Research, Inveready, CDTI Innvierte and Clave Capital. CONNECTA Therapeutics is based in Barcelona, Catalonia, Spain.
- How much did CONNECTA Therapeutics raise?
- CONNECTA Therapeutics raised €3.1 Million in a Seed round on September 10, 2026.
- Who invested in CONNECTA Therapeutics?
- Prous Institute For Biomedical Research, Inveready, CDTI Innvierte and Clave Capital are named as investors in this round.
- What does CONNECTA Therapeutics do?
- CONNECTA Therapeutics is a clinical-stage biotech company leveraging its small-molecule neuroplasticity modulation platform to address unmet medical needs in central nervous system (CNS) disorders.
- Where is CONNECTA Therapeutics based and how big is it?
- CONNECTA Therapeutics is based in Barcelona, Catalonia, Spain. Fundz records about 9 employees.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as CONNECTA Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
- Pathos AI raised $237M (Series E) on October 23, 2026.
- Trior raised $25M (Series C) on October 23, 2026.
- Arctic Therapeutics raised $22M on October 21, 2026.
- Disc raised $422M (Post-IPO Equity) on October 20, 2026.
- Nouscom raised $135M (Series D) on October 19, 2026.
Who to call at CONNECTA Therapeutics, and when
A new round usually means CONNECTA Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day CONNECTA Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CONNECTA Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CONNECTA Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CONNECTA Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
CONNECTA Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.